DrugPatentWatch Database Preview

Cenobamate - Generic Drug Details

« Back to Dashboard

What are the generic sources for cenobamate and what is the scope of patent protection?

Cenobamate is the generic ingredient in one branded drug marketed by Sk Life and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Cenobamate has twenty-two patent family members in eighteen countries.

Summary for cenobamate

International Patents:	22
US Patents:	1
Tradenames:	1
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	8
Clinical Trials:	9
Patent Applications:	40
What excipients (inactive ingredients) are in cenobamate?	cenobamate excipients list
DailyMed Link:	cenobamate at DailyMed

Recent Clinical Trials for cenobamate

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
SK Life Science, Inc.	Phase 1
SK Life Science, Inc.	Phase 3
SK Life Science	Phase 1

See all cenobamate clinical trials

US Patents and Regulatory Information for cenobamate

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sk Life	XCOPRI	cenobamate	TABLET;ORAL	212839-004	Mar 10, 2020		RX	Yes	No
Sk Life	XCOPRI	cenobamate	TABLET;ORAL	212839-005	Mar 10, 2020		RX	Yes	No				Y
Sk Life	XCOPRI	cenobamate	TABLET;ORAL	212839-001	Mar 10, 2020		RX	Yes	Yes				Y
Sk Life	XCOPRI	cenobamate	TABLET;ORAL	212839-006	Mar 10, 2020		RX	Yes	No				Y
Sk Life	XCOPRI	cenobamate	TABLET;ORAL	212839-002	Mar 10, 2020		RX	Yes	No

International Patents for cenobamate

Country	Patent Number	Estimated Expiration
South Korea	20080005437
China	101228138
Portugal	1879873
South Korea	101286499
Argentina	053065

Supplementary Protection Certificates for cenobamate

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1879873	301106	Netherlands		PRODUCT NAME: CENOBAMAAT OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/21/1530 20210330
1879873	CA 2021 00015	Denmark		PRODUCT NAME: CENOBAMAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/21/1530 20210330
1879873	122021000027	Germany		PRODUCT NAME: CENOBAMAT; REGISTRATION NO/DATE: EU/1/21/1530 20210326